Zota Health Care Share Price

NSE
ZOTA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Zota Health Care
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
27.27% Fall from 52W High
18.3
Dividend yield 1yr %
Low in industry
0.1

Zota Health Care Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Zota Health Care Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
72.12 Cr
67.28 Cr
56.3 Cr
49.64 Cr
46.93 Cr

Zota Health Care Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
181.64 Cr
141.91 Cr
132.82 Cr
108.05 Cr
96.63 Cr

Zota Health Care Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
-18.95 Cr
-12.18 Cr
-12.72 Cr
-6.92 Cr
-2.94 Cr

Zota Health Care Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
-14.35 Cr
-5.77 Cr
8.91 Cr
-0.21 Cr
2.74 Cr
Zota Health Care Result Highlights
  • Zota Health Care Ltd reported a 7.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 54.3%.

  • Its expenses for the quarter were up by 13.2% QoQ and 82.9% YoY.

  • The net profit increased 55.5% QoQ and increased 544.2% YoY.

  • The earnings per share (EPS) of Zota Health Care Ltd declined at 6.3 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Zota Health Care shareholding Pattern

Promoter
62%
Foreign Institutions
0.2%
Domestic Institutions
1.1%
Public
36.5%
Promoter
62.4%
Domestic Institutions
1%
Public
36.4%
Promoter
64.4%
Public
35.4%
Promoter
66.2%
Public
33%
Promoter
66.2%
Public
33%
Promoter
66.2%
Public
33%

Zota Health Care Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
12
5Day EMA
798.60
10Day EMA
813.30
12Day EMA
819.10
20Day EMA
839.70
26Day EMA
849.90
50Day EMA
852.60
100Day EMA
803.90
200Day EMA
718.20
5Day SMA
803.00
10Day SMA
811.50
20Day SMA
838.80
30Day SMA
881.90
50Day SMA
911.10
100Day SMA
780.20
150Day SMA
735.70
200Day SMA
694.50
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
55543 Rs
76569 Rs
Week Rs
21333 Rs
33773 Rs
Month Rs
26703 Rs
51256 Rs
Resistance & Support
793.32
Pivot
Resistance
First Resistance
809.63
Second Resistance
835.27
Third Resistance
851.58
Support
First Support
767.68
Second support
751.37
Third Support
725.73
Relative Strength Index
34.99
Money Flow Index
24.86
MACD
-30.80
MACD Signal
-26.20
Average True Range
43.29
Average Directional Index
13.43
Rate of Change (21)
-15.63
Rate of Change (125)
17.43

Zota Health Care Company background

Founded in: 2000
Managing director: Moxesh Zota
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and overthecounter (OTC) products. The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat. The Company meets the requirements of millions of people by increasing access to highquality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving Indias pharmaceutical industry a boost.The Company has three business verticals: Marketinga traditional business vertical, and driving business verticals Exports and Retail harmacy Chain. Through its chain, Davaindia, the largest privatesector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business. The Companys stateoftheart manufacturing facility at Sachin SEZ serves customers in more than 30 countries. Davaindia is a retail generic pharmacy chain whose core value proposition is providing quality generic medicines at substantial discounts, i.e. 30% to 90%, to their branded equivalents. Davaindia focuses on privatelabel products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments.The Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Companys distribution network across India. In domestic Marketing business, the Company procures finished dosage forms (FDFs) from domestic formulation manufactures and then market them under its portfolio of brands. It has a set of manufacturing partners recognized by the WHO with a rigorous focus on product quality. With a portfolio of more than 3000 products in various categories, such as generics, OTC products, allopathic, ayurvedic, etcetera, the Company cater to a variety of ailments. Currently, the Company has over 1050 distributors spread around the country. Instead of the Company directly engaging in sales, distribution, and promotion activities, its distributors engage in ethical marketing or other sales, distribution, and promotion activities on their own. Instead, it provide distributors directly with incentives to help them sell products more effectively.Secondly, the exports business vertical started in 2010, following the establishment of formulations manufacturing facility in the Sachin SEZ. The Company is required to export products from this unit in accordance with the laws governing this SEZ. At present, it has product approvals in 30 countries, particularly in the semiregulated and regulated markets in the African, Asian, CIS, and Latin American countries. In this facility, the Company make around 250 formulations for direct exports and contract manufacturing. . At present, the Company has 253 dossiers approved across multiple countries, and another 311 dossiers have been filed and are pending approval. It significantly increased efforts and investments towards product registration, the results of which are now apparent in the form of product approvals and expansion of export operations. In the Retail Pharmacy Chain business vertical, the Company operates a chain of pharmacy stores under the brand Davaindia. Davaindia focuses only on privatelabel products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments. This concept started with three pilot stores in 2017 and has been scaled up to become the largest privatesector generic pharmacy chain with more than 591 stores as of March 2021. Davaindia operates on a unique assetlight franchise model for majority stores. These stores are engaged in exclusive sales of Davaindia products, with more than 95% of products being privatelabel. In all areas and media, such as TV commercials, printing, digital social media, radio, among others, the Company has undertaken bold and aggressive marketing and promotion activities with the firm intention of creating topofthemind brand recall for Davaindia. Davaindia being a frontrunner in private sector generic pharmacy assumed the responsibility to create awareness, propagate virtues and debunk misconceptions about generic drugs. In 2019, the Company opened 150 Davaindia outlets. Davaindia expanded to over 250 outlets, becoming the fastestgrowing privatesector generic pharmacy chain in India in 2020.
Read More

Zota Health Care FAQs

Zota Health Care share price in the past 1-year return was 70.62. The Zota Health Care share hit a 1-year low of Rs. 440.1 and a 1-year high of Rs. 1078.

The market cap of Zota Health Care is Rs. 2161.57 Cr. as of 12/3/2025.

The PE ratios of Zota Health Care is 346.9 as of 12/3/2025.

The PB ratios of Zota Health Care is 9.48 as of 12/3/2025

The Mutual Fund Shareholding in Zota Health Care was 0.03% at the end of 12/3/2025.

You can easily buy Zota Health Care shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Zota Health Care stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -